| Douglas S Smith, MD | |
|
N84 W16889 Menomonee Ave, Menomonee Falls, WI 53051 | |
| (262) 251-7500 | |
| (262) 251-7128 |
| Full Name | Douglas S Smith |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | N84 W16889 Menomonee Ave, Menomonee Falls, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821020058 | NPI | - | NPPES |
| 30747600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 27805 (Wisconsin) | Primary |
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Moffitt Cancer Center and CvergenX, Inc., announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™. Researchers at Moffitt have used gene expression analysis and systems biology to create a radio-sensitivity classification index for individual tumors.
The New York Times reports on a growing movement in Senegal to end female genital cutting, which was officially banned in the nation more than a decade ago. "The change is happening without the billions of dollars that have poured into other global health priorities throughout the developing world in recent years," the newspaper writes.
News outlets offer a variety of coverage on these issues - including how Medicare is playing in the polls and what motivates senior voters. And a new Families USA study offers a critical assessment of Mitt Romney's health policies.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its Opana(R) ER (oxymorphone hydrochloride) extended-release tablets, 5 mg, 10 mg, 20 mg and 40 mg.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas S Smith, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (262) 251-7500 | Douglas S Smith, MD N84 W16889 Menomonee Ave, Menomonee Falls, WI 53051 Ph: (262) 251-7500 |
News Archive
Moffitt Cancer Center and CvergenX, Inc., announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™. Researchers at Moffitt have used gene expression analysis and systems biology to create a radio-sensitivity classification index for individual tumors.
The New York Times reports on a growing movement in Senegal to end female genital cutting, which was officially banned in the nation more than a decade ago. "The change is happening without the billions of dollars that have poured into other global health priorities throughout the developing world in recent years," the newspaper writes.
News outlets offer a variety of coverage on these issues - including how Medicare is playing in the polls and what motivates senior voters. And a new Families USA study offers a critical assessment of Mitt Romney's health policies.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its Opana(R) ER (oxymorphone hydrochloride) extended-release tablets, 5 mg, 10 mg, 20 mg and 40 mg.
› Verified 6 days ago
Ms. Laura L. Franck, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: W180n8000 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 Fax: 262-253-9501 | |
Lara Totzke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: W180n7950 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 | |
Dr. Brett A Barkimer, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: W129n7055 Northfield Dr, Menomonee Falls, WI 53051 Phone: 262-253-2510 Fax: 262-253-3399 | |
Soniya K Pawar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500 | |
Samir Sabnis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: W180n7950 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 | |
Karen M Jacobson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: N84 W16889 Menomonee Avenue, Menomonee Falls, WI 53051 Phone: 262-251-7500 Fax: 262-251-7128 | |
Lourdes Edelmina Santiago, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: W180n7950 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 |